Chemokine inhibiting piperazine derivatives and their use to treat multiple myeloma

Details for Australian Patent Application No. 2005212290 (hide)

Owner Schering Aktiengesellschaft The University of Pittsburgh of the Commonwealth of Higher Education

Inventors Choi, Sun Jin; Horuk, Richard; Roodman, G. David

Agent Davies Collison Cave

Pub. Number AU-A-2005212290

PCT Pub. Number WO2005/077372

Priority 60/542,809 06.02.04 US

Filing date 4 February 2005

Wipo publication date 25 August 2005

International Classifications

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

Event Publications

28 September 2006 PCT application entered the National Phase

  PCT publication WO2005/077372 Priority application(s): WO2005/077372

13 November 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005212291-Razor assembly

2005212284-Surface treating device with cartridgebased cleaning system